Search results
Results from the WOW.Com Content Network
COVID-19 vaccine production by country Country Doses (millions) 3 Mar 2021 [1] 31 Jan 2022 [2]; China 141.6: 4951.4 European Union 81.0: 2459.9 India 42.4: 1807.8
According to Oxfam's calculations, a one-time 99% windfall tax on the gains in fortunes of the 10 richest men would able be to pay for the manufacture of the world's COVID-19 vaccines. There'd ...
In contrast to research and development, the vaccine production market, even for out-of-patent vaccines, is highly concentrated. 80% of global production is in the hand of five large companies, which hold key patents. [6] [7] This reduces competition and allows high, uncompetitive prices, often more than 100 times the cost of production. [8] [9]
95.2% of the eligible Australian population aged 12+ are fully vaccinated 64.5% of the eligible Australian population aged 12+ are booster given Website Department of Health and Aged Care A poster released in March 2021, part of the Australian Government's COVID-19 vaccination rollout A poster from the government's vaccination campaign rolled out in July 2021, titled "Arm yourself against ...
The claim: Japan declared COVID-19 vaccine is ‘the most deadly drug in history’ A Nov. 8 Facebook post (direct link, archive link) claims another country issued a dire warning about the COVID ...
Yoshihide Suga, the prime minister of Japan vaccinated with a COVID-19 vaccine. COVID-19 vaccination in Japan started later than in most other major economies. [4] The country has frequently been regarded as "slow" in its vaccination efforts. [5] [6] Japan has so far approved Pfizer–BioNTech, Moderna and Oxford–AstraZeneca for use.
Boxes of AstraZeneca's COVID-19 vaccine from India are delivered in Brazil (January 2021). Coordination of international air cargo is an essential component of time- and temperature-sensitive distribution of COVID‑19 vaccines, but, as of September 2020, the air freight network is not prepared for multinational deployment.
UNICEF announced that it will be leading global procurement and fair and equitable supply of COVID-19 vaccinations when they are available. [5] The WHO announced that the COVID-19 pandemic had caused massive global disruption in diagnosing and treating people with deadly but preventable diseases, including over half of cancer patients. [6]